Reagan Aides Question His Pact With Japan

Some advisers doubt the Japanese will comply with the terms of the science treaty signed in Canada last June WASHINGTON—The ink had hardly dried on the agreement signed by Ronald Reagan and Prime Minister Noboru Takeshita to foster United States-Japan cooperation in science when the sniping began. But the snipers weren’t Democrats running for office, nor were they diplomats representing Japan’s commercial rivals. The criticism was coming from hardliners in the White House

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—The ink had hardly dried on the agreement signed by Ronald Reagan and Prime Minister Noboru Takeshita to foster United States-Japan cooperation in science when the sniping began. But the snipers weren’t Democrats running for office, nor were they diplomats representing Japan’s commercial rivals. The criticism was coming from hardliners in the White House— including members of the president’s Office of Science and Technology Policy.

“This country has experienced past situations in which the Japanese have promised to do something and then didn’t follow through,” warns Deborah ‘Wince, assistant director for international affairs within the office.

That view casts doubt on the common wisdom flowing from the June 20 ceremony at the Toronto economic summit that the five-year agreement marks the end of a bitter feud between the two economic powers on access to research facilities. The agreement covers potential cooperation in a range of disciplines, ranging from biotechnology to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies